Lenvatinib
Cat. No.：YN440128
CAS No. ：417716-92-8
规格
价格(RMB)
库存
| 产品名称: | Lenvatinib |
| CAS No.: | 417716-92-8 |
| Chemical Name: | 4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide |
| Synonyms: | 仑伐替尼; E7080 |
| 分子量: | 426.85 |
| 分子式: | C₂₁H₁₉ClN₄O₄ |
| SMILES: | O=C(N)C1=C(C=C2N=CC=C(C2=C1)OC3=CC=C(C(Cl)=C3)NC(NC4CC4)=O)OC |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Lenvatinib (E7080) 一种具有口服活性的，多靶点酪氨酸激酶抑制剂，抑制血管内皮生长因子受体(VEGFR1-3)，成纤维细胞生长因子受体(FGFR1-4)，血小板衍生生长因子受体(PDGFR)，干细胞因子受体(KIT)，转染期间重排(RET)，显示有效抗癌的活性。 |
| IC50和靶点: | [{name:"VEGFR1:22 nM (IC50)"},{name: "VEGFR2:4 nM (IC50)"},{name: "VEGFR3:5.2 nM (IC50)"},{name: "FGFR1:46 nM (IC50)'}, 'FGFR2', 'FGFR3', 'FGFR4', {'PDGFRα:51 nM (IC50)"},{name: "PDGFRβ:39 nM (IC50)"},{name: "c-Kit:100 nM (IC50)'}, 'RET'] |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Matsui, J., Yamamaoto, Y., Funahashi, Y., et al.E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibitionInt. J. Cancer122(3),664-671(2008)
Matsui, J., Funahashi, Y., Uenaka, T., et al.Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinaseClin. Cancer Res.14(17),5459-5465(2008)
